Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

APOE anticorps (N-Term)

Il existe 3+ publications pour ce produit. L’anticorps anti-APOE Polyclonal Lapin est utilisé pour la détection de APOE dans des échantillons de Humain. Il a été validé pour WB et IHC.
N° du produit ABIN503507
150,78 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour APOE anticorps (N-Term) (ABIN503507)

Antigène

Voir toutes APOE Anticorps
APOE (Apolipoprotein E (APOE))

Reactivité

  • 125
  • 92
  • 59
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 122
  • 36
  • 10
  • 2
  • 1
Lapin

Clonalité

  • 112
  • 58
Polyclonal

Conjugué

  • 80
  • 19
  • 10
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Cet anticorp APOE est non-conjugé

Application

  • 131
  • 59
  • 54
  • 39
  • 39
  • 30
  • 26
  • 21
  • 21
  • 12
  • 8
  • 6
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Épitope

    • 15
    • 15
    • 15
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Séquence

    KVLWAALLVT FLAGCQAKVE QAVETEPEPE LRQQTEWQSG QRWELALGRF

    Homologie

    Human: 100%

    Attributs du produit

    This is a rabbit polyclonal antibody against APOE. It was validated on Western Blot using a cell lysate as a positive control.

    Purification

    Affinity Purified

    Immunogène

    The immunogen is a synthetic peptide directed towards the N terminal region of human APOE
  • Indications d'application

    Optimal working dilutions should be determined experimentally by the investigator.

    Commentaires

    Antigen size: 317 AA

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
  • Day, McCarty, Ockerse, Head, Rohn: "Proteolytic Cleavage of Apolipoprotein E in the Down Syndrome Brain." dans: Aging and disease, Vol. 7, Issue 3, pp. 267-77, (2016) (PubMed).

    Rohn, Day, Sheffield, Rajic, Poon: "Apolipoprotein E pathology in vascular dementia." dans: International journal of clinical and experimental pathology, Vol. 7, Issue 3, pp. 938-47, (2014) (PubMed).

    Rohn, Catlin, Coonse, Habig: "Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brain." dans: Brain research, Vol. 1475, pp. 106-15, (2012) (PubMed).

  • Antigène

    APOE (Apolipoprotein E (APOE))

    Autre désignation

    APOE

    Sujet

    Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells. ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. Defects in apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants.Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells. ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. The APOE gene is mapped to chromosome 19 in a cluster with APOC1 and APOC2. Defects in apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
    Alias Symbols: AD2, MGC1571, apoprotein, LPG, LDLCQ5
    Protein Interaction Partner: LCAT, ARFGAP1, ALB, C19orf52, LOXL4, PRAM1, MID1IP1, ANKH, FBXL12, FXYD7, ECSIT, PDCD4, IFIT5, MAST1, EPN2, PLEKHA6, CDC37, IQSEC1, LONP1, TYRO3, PRDX2, ST13, RPL4, RHEB, PSEN1, HTRA1, PCMT1, ZNF558, NOS3, IFIT3, GCDH, FOXG1, FARSA, ELAVL1, CYP2C18, CYP2C
    Protein Size: 317

    Poids moléculaire

    34 kDa

    ID gène

    348

    NCBI Accession

    NM_000041, NP_000032

    UniProt

    P02649

    Pathways

    Regulation of Cell Size, Lipid Metabolism
Vous êtes ici:
Chat with us!